SitesBLAST
Comparing 14398 FitnessBrowser__Keio:14398 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
P25737 Lysine-specific permease LysP; Lysine transporter LysP; Trigger transporter LysP from Escherichia coli (strain K12) (see 2 papers)
40% identity, 92% coverage: 2:429/467 of query aligns to 4:438/489 of P25737
- Y102 (= Y99) mutation to L: Retains 4% of wild-type lysine uptake activity. Increases the capacity to inhibit CadC in the presence of lysine.
- W106 (= W103) mutation to L: Retains 20% of wild-type lysine uptake activity. Increases the capacity to inhibit CadC in the presence of lysine.
- K163 (= K160) mutation to A: Retains 24% of wild-type lysine uptake activity. Increases the capacity to inhibit CadC in the presence of lysine.
- F216 (= F215) mutation to L: Retains 13% of wild-type lysine uptake activity. Increases the capacity to inhibit CadC in the presence of lysine.
- E222 (= E221) mutation to A: Abolishes lysine uptake. Strongly inhibits CadC.
- E230 (= E229) mutation to V: Abolishes lysine uptake. Shows significant less inhibition of CadC.
- D275 (vs. gap) Essential for the stimulus-dependent interaction with CadC; mutation to A: Retains 88% of wild-type lysine uptake activity, but can hardly inhibit CadC. Cannot interact with CadC; when associated with A-278.
- D278 (≠ G269) Essential for the stimulus-dependent interaction with CadC; mutation to A: Retains 88% of wild-type lysine uptake activity, but can hardly inhibit CadC. Cannot interact with CadC; when associated with A-275.
- E438 (≠ D429) mutation to A: Retains 14% of wild-type lysine uptake activity. Is unable to inhibit CadC.
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 443 D→A: Retains 11% of wild-type lysine uptake activity. Is unable to inhibit CadC.
- 446 D→A: Retains 13% of wild-type lysine uptake activity. Is unable to inhibit CadC.
P46349 Gamma-aminobutyric acid permease; GABA permease; 4-aminobutyrate permease; Gamma-aminobutyrate permease; Proline transporter GabP from Bacillus subtilis (strain 168) (see paper)
37% identity, 98% coverage: 4:461/467 of query aligns to 2:454/469 of P46349
- G33 (≠ N35) mutation to D: Lack of activity.
- G42 (= G44) mutation to S: Lack of activity.
- G301 (= G306) mutation to V: Lack of activity.
- G338 (≠ S343) mutation to E: Lack of activity.
- F341 (≠ G346) mutation to S: Lack of activity.
- G414 (vs. gap) mutation to R: Lack of activity.
P15993 Aromatic amino acid transport protein AroP; Aromatic amino acid:H(+) symporter AroP; General aromatic amino acid permease; General aromatic transport system from Escherichia coli (strain K12) (see paper)
35% identity, 99% coverage: 1:464/467 of query aligns to 2:457/457 of P15993
- Y103 (≠ W103) Key residue for tryptophan transport; mutation to F: Decreases tryptophan transport to less than 50% of wild-type levels and reduces the ability of tryptophan to inhibit phenylalanine transport from 95 to 62%.
P24207 Phenylalanine-specific permease; Phenylalanine:H(+) symporter PheP from Escherichia coli (strain K12) (see 3 papers)
35% identity, 94% coverage: 4:444/467 of query aligns to 13:451/458 of P24207
- R26 (= R17) mutation R->G,S,Q: Strong decrease in phenylalanine transport activity.
- P54 (≠ A45) mutation to A: 50% of wild-type phenylalanine transport activity.; mutation to G: No change in phenylalanine transport activity.; mutation to L: 26% of wild-type phenylalanine transport activity.
- F87 (= F79) mutation to L: No effect on phenylalanine transport activity.
- F90 (≠ Y82) mutation to L: 65% of wild-type phenylalanine transport activity.
- Y92 (≠ A84) mutation to L: 41% of wild-type phenylalanine transport activity.
- Y94 (= Y86) mutation to L: 69% of wild-type phenylalanine transport activity.
- W95 (≠ L87) mutation to L: 10% of wild-type phenylalanine transport activity.
- F98 (≠ A90) mutation to L: No effect on phenylalanine transport activity.
- F101 (≠ Y93) mutation to L: 38% of wild-type phenylalanine transport activity.
- W105 (= W97) mutation to L: 39% of wild-type phenylalanine transport activity.
- Y107 (= Y99) mutation to L: No effect on phenylalanine transport activity.
- W108 (= W100) mutation to L: 71% of wild-type phenylalanine transport activity.
- F111 (≠ W103) mutation to L: 60% of wild-type phenylalanine transport activity.; mutation to Y: Enables the transport of tryptophan to almost the same steady-state level as that of phenylalanine.
- E118 (≠ S110) mutation E->G,L,V,N: Loss of activity.
- K168 (= K160) mutation K->L,R: Strong decrease in phenylalanine transport activity.; mutation to N: Loss of activity.
- E226 (= E221) mutation E->A,Q,K,R,W: Loss of activity.
- R252 (= R247) mutation R->D,E,F,W,P: Loss of activity.
- P341 (= P336) mutation to A: 5% of wild-type phenylalanine transport activity.; mutation P->G,Q,K,R: Loss of activity.; mutation to S: 3% of wild-type phenylalanine transport activity.; mutation to T: 17% of wild-type phenylalanine transport activity.
- P442 (≠ A435) mutation to A: 46% of wild-type phenylalanine transport activity.; mutation to G: 52% of wild-type phenylalanine transport activity.; mutation to L: 43% of wild-type phenylalanine transport activity.
P04817 Arginine permease CAN1; Canavanine resistance protein 1 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see paper)
35% identity, 87% coverage: 6:409/467 of query aligns to 80:496/590 of P04817
- P113 (≠ I39) mutation to L: In CAN1-343; confers citrulline transport activity in GAP1-deleted cells.
- P148 (= P74) mutation to L: In CAN1-337; confers citrulline transport activity in GAP1-deleted cells and leads to sensitivity to L-glutamic acid alpha-hydroxamate, alpha-aminoisobutyrate, 3-chloro-L-alanine, L-ethionine, L-allylglycine, and D-histidine, but not sensitivity to L-aspartic acid alpha-hydroxamate or p-fluoro-L-phenylalanine.
- V149 (≠ E75) mutation to F: In CAN1-315; confers citrulline transport activity in GAP1-deleted cells.
- S152 (≠ A78) mutation to F: In CAN1-342; confers citrulline transport activity in GAP1-deleted cells.
- Y173 (= Y99) mutation to D: In CAN1-306; confers citrulline transport activity in GAP1-deleted cells.; mutation to H: In CAN1-327; confers citrulline transport activity in GAP1-deleted cells.
- G308 (= G228) mutation to A: In CAN1-341; confers citrulline transport activity in GAP1-deleted cells.
- P313 (= P233) mutation to S: In CAN1-329; confers citrulline transport activity in GAP1-deleted cells and leads to sensitivity to L-glutamic acid alpha-hydroxamate, alpha-aminoisobutyrate, 3-chloro-L-alanine, L-ethionine, L-allylglycine, and D-histidine, L-aspartic acid alpha-hydroxamate and p-fluoro-L-phenylalanine.
- TS 354:355 (vs. gap) mutation Missing: In CAN1-318; confers citrulline transport activity in GAP1-deleted cells.
- Y356 (vs. gap) mutation to H: In CAN1-340; confers citrulline transport activity in GAP1-deleted cells.; mutation to N: In CAN1-339; confers citrulline transport activity in GAP1-deleted cells.
- W451 (≠ A364) mutation to C: In CAN1-328; confers citrulline transport activity in GAP1-deleted cells.; mutation to L: In CAN1-316; confers citrulline transport activity in GAP1-deleted cells.; mutation to S: In CAN1-335; confers citrulline transport activity in GAP1-deleted cells.
- F461 (≠ V374) mutation to S: In CAN1-307; confers citrulline transport activity in GAP1-deleted cells.
Q9URZ4 Cationic amino acid transporter 1 from Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) (see paper)
32% identity, 90% coverage: 3:422/467 of query aligns to 73:503/587 of Q9URZ4
Sites not aligning to the query:
- 29 modified: Phosphoserine
- 30 modified: Phosphoserine
- 37 modified: Phosphoserine
P48813 High-affinity glutamine permease from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see paper)
33% identity, 92% coverage: 1:430/467 of query aligns to 136:579/663 of P48813
Sites not aligning to the query:
- 132 modified: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
P19145 General amino-acid permease GAP1 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see 3 papers)
31% identity, 86% coverage: 7:406/467 of query aligns to 83:493/602 of P19145
- A297 (≠ S218) mutation to V: Impairs basic amino-acids transport and regulation by these amino-acids.
Sites not aligning to the query:
- 76 modified: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
Q03770 SPS-sensor component SSY1; Amino-acid permease homolog SSY1 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see paper)
24% identity, 88% coverage: 10:419/467 of query aligns to 277:763/852 of Q03770
- T382 (≠ G115) mutation T->H,L: Constitutively active, up-regulates amino acid permease transcription in response to subthreshold concentrations of amino acids.; mutation to K: In SSY1-102; constitutively active, up-regulates amino acid permease transcription in the absence of amino-acids.; mutation to R: Constitutively active, up-regulates amino acid permease transcription in the absence of amino acids.
5j4nA Crystal structure of the l-arginine/agmatine antiporter adic in complex with agmatine at 2.6 angstroem resolution (see paper)
25% identity, 86% coverage: 25:425/467 of query aligns to 17:400/437 of 5j4nA
P60061 Arginine/agmatine antiporter from Escherichia coli (strain K12) (see 3 papers)
25% identity, 86% coverage: 25:425/467 of query aligns to 21:404/445 of P60061
- I23 (≠ V27) binding ; binding
- S26 (≠ T30) binding
- Y93 (= Y99) mutation to L: Greatly decreased Arg uptake into liposomes.
- A96 (≠ T102) binding ; binding
- C97 (vs. gap) binding
- N101 (≠ A106) binding ; mutation to A: Vmax for Arg-Agm exchange 1% of wild-type, KM increases 3-fold.; mutation to D: Nearly wild-type Arg-Agm exchange.
- M104 (≠ S109) binding ; mutation to A: 30% decreased affinity for Arg, 50% decreased affinity for Agm.
- W202 (≠ F215) binding ; mutation to L: Halves Arg uptake into liposomes.
- S203 (≠ A216) binding
- I205 (≠ S218) binding ; binding ; mutation to A: About wild-type affinity for Arg and Agm.
- W293 (≠ G306) binding ; mutation W->C,H,L: Loss of Arg-Agm exchange.; mutation W->F,Y: Less than 20% Arg-Agm exchange activity. Vmax 15% of wild-type rate.
- S357 (= S369) binding ; mutation to A: 20% decreased affinity for Arg, 40% decrease affinity for Agm.
P60063 Arginine/agmatine antiporter from Escherichia coli O157:H7 (see 3 papers)
25% identity, 86% coverage: 25:425/467 of query aligns to 21:404/445 of P60063
- N22 (≠ G26) mutation to A: No change in antiport activity, 6-fold higher affinity for Arg.
- I23 (≠ V27) binding
- GSG 25:27 (≠ GTG 29:31) Helix-breaking GSG motif TM1
- S26 (≠ T30) binding ; mutation to K: 5% Agm antiport.
- G27 (= G31) binding
- Y74 (≠ H80) mutation to A: 50% antiport activity at pH 6.0, 10-fold higher than wild-type antiport activity at pH 7.5, i.e. loss of pH-dependence of substrate transport. No change in binding of Arg or Agm.; mutation Y->C,H,L,M,Q,S: Loss of pH-dependence of substrate transport.; mutation to F: Approximately wild-type antiport.
- Y87 (= Y93) mutation to A: Markedly reduced binding affinity for Agm but not for Arg. 50% Agm antiport.
- Y93 (= Y99) mutation to A: Reduced binding affinity for Arg, no binding to Agm. 25% Agm antiport.; mutation to K: Almost no binding to both Arg and Agm. 5% Agm antiport.
- A96 (≠ T102) binding
- C97 (vs. gap) binding
- N101 (≠ A106) binding
- W202 (≠ F215) Periplasmic (proximal) gate; binding
- I205 (≠ S218) binding
- GVESA 206:210 (≠ GTELI 219:223) Helix-breaking GVESA motif TM6
- E208 (= E221) mutation E->A,D: 5-10% Agm antiport.
- W293 (≠ G306) binding
- F337 (= F352) mutation to A: Severely decreased antiport.
- S357 (= S369) binding
- Y365 (≠ W377) mutation to A: Markedly weakened binding to Arg but not to Agm. 5% Agm antiport.
3l1lA Structure of arg-bound escherichia coli adic (see paper)
25% identity, 86% coverage: 25:425/467 of query aligns to 15:387/423 of 3l1lA
P76037 Putrescine importer PuuP from Escherichia coli (strain K12) (see paper)
24% identity, 98% coverage: 10:467/467 of query aligns to 18:454/461 of P76037
- Y110 (≠ W103) mutation to X: The uptake activity is reduced to one-eighth of that of wild-type.
6f34A Crystal structure of a bacterial cationic amino acid transporter (cat) homologue bound to arginine. (see paper)
22% identity, 90% coverage: 2:419/467 of query aligns to 15:421/458 of 6f34A
- binding arginine: I40 (≠ V27), G42 (= G29), T43 (= T30), G44 (= G31), E115 (≠ T102), Y116 (≠ W103), A119 (= A106), F228 (= F215), A229 (= A216), I231 (≠ S218), V314 (≠ A302)
- binding cholesterol: W201 (≠ S191), Y202 (≠ N192)
- binding : G28 (≠ K15), F30 (≠ R17), D31 (≠ H18), M34 (= M21), A178 (= A174), R179 (≠ I175), A186 (≠ Q182), I187 (≠ D183), A190 (≠ P186), L194 (vs. gap), Q296 (≠ I284), V299 (≠ A287)
5oqtA Crystal structure of a bacterial cationic amino acid transporter (cat) homologue (see paper)
22% identity, 90% coverage: 2:419/467 of query aligns to 13:419/456 of 5oqtA
- binding alanine: I38 (≠ V27), G40 (= G29), T41 (= T30), G42 (= G31), F226 (= F215), A227 (= A216), I229 (≠ S218)
- binding : E24 (≠ T13), G26 (≠ K15), F28 (≠ R17), D29 (≠ H18), M32 (= M21), A176 (= A174), R177 (≠ I175), A184 (≠ Q182), A188 (≠ P186), L192 (vs. gap), Q294 (≠ I284), V297 (≠ A287)
6f2wA Bacterial asc transporter crystal structure in open to in conformation (see paper)
22% identity, 84% coverage: 24:417/467 of query aligns to 14:393/433 of 6f2wA
O34739 Serine/threonine exchanger SteT from Bacillus subtilis (strain 168) (see paper)
21% identity, 88% coverage: 4:414/467 of query aligns to 3:395/438 of O34739
- C94 (≠ V95) mutation to S: Retains 25% of the transport activity; when associated with S-141; S-168; S-291 and S-415.
- C141 (≠ A136) mutation to S: Retains 25% of the transport activity; when associated with S-94; S-168; S-291 and S-415.
- C168 (≠ A166) mutation to S: Retains 25% of the transport activity; when associated with S-94; S-141; S-291 and S-415.
- C291 (≠ A302) mutation to S: Retains 25% of the transport activity; when associated with S-94; S-141; S-168 and S-415.
Sites not aligning to the query:
- 415 C→S: Retains 25% of the transport activity; when associated with S-94; S-141; S-168 and S-291.
P30825 High affinity cationic amino acid transporter 1; CAT-1; CAT1; Ecotropic retroviral leukemia receptor homolog; Ecotropic retrovirus receptor homolog; Solute carrier family 7 member 1; System Y+ basic amino acid transporter from Homo sapiens (Human) (see paper)
22% identity, 71% coverage: 1:332/467 of query aligns to 19:380/629 of P30825
- N226 (≠ P186) modified: carbohydrate, N-linked (GlcNAc...) asparagine
P0AAE8 Cadaverine/lysine antiporter from Escherichia coli (strain K12) (see paper)
21% identity, 77% coverage: 68:425/467 of query aligns to 59:403/444 of P0AAE8
- Y73 (= Y82) mutation to L: Strong decrease in both cadaverine excretion and cadaverine uptake. 9-fold increase in Km for cadaverine for cadaverine uptake and 10-fold increase in Km for cadaverine for cadaverine excretion.
- E76 (≠ R85) mutation to Q: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- Y89 (= Y99) mutation to L: Strong decrease in both cadaverine excretion and cadaverine uptake. 10-fold increase in Km for cadaverine for cadaverine uptake and 5-fold increase in Km for cadaverine for cadaverine excretion.
- Y90 (≠ W100) mutation to L: Strong decrease in both cadaverine excretion and cadaverine uptake.
- Y107 (≠ F116) mutation to L: Strong decrease in cadaverine uptake.
- C125 (= C131) mutation to S: Does not affect cadaverine excretion and cadaverine uptake.
- Y174 (≠ P186) mutation to L: Moderate decrease in cadaverine uptake.
- D185 (≠ F199) mutation to N: Moderate decrease in cadaverine uptake.
- C196 (≠ V213) mutation to S: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- E204 (= E221) mutation to Q: Strong decrease in both cadaverine excretion and cadaverine uptake. 22-fold increase in Km for cadaverine for cadaverine uptake and 6-fold increase in Km for cadaverine for cadaverine excretion.
- Y235 (≠ F252) mutation to L: Strong decrease in both cadaverine excretion and cadaverine uptake. 23-fold increase in Km for cadaverine for cadaverine uptake and 7-fold increase in Km for cadaverine for cadaverine excretion.
- Y246 (≠ I263) mutation to L: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- C282 (≠ I299) mutation to S: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- R299 (≠ S316) mutation to A: Strong decrease in cadaverine excretion but not in cadaverine uptake.
- D303 (≠ E320) mutation to N: Strong decrease in both cadaverine excretion and cadaverine uptake. 24-fold increase in Km for cadaverine for cadaverine uptake and 9-fold increase in Km for cadaverine for cadaverine excretion.
- Y310 (≠ F327) mutation to L: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- Y366 (≠ W377) mutation to L: Strong decrease in cadaverine uptake. 15-fold increase in Km for cadaverine for cadaverine uptake.
- Y368 (≠ S379) mutation to L: Strong decrease in cadaverine uptake.
- C370 (= C381) mutation to S: Strong decrease in both cadaverine excretion and cadaverine uptake.
- E377 (≠ R388) mutation to Q: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- C389 (≠ V411) mutation to S: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- C394 (≠ F416) mutation to S: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- C397 (= C419) mutation to S: Moderate decrease in both cadaverine excretion and cadaverine uptake.
Sites not aligning to the query:
- 12 C→S: Does not affect cadaverine excretion and cadaverine uptake.
- 41 W→L: Moderate decrease in cadaverine uptake.
- 43 W→L: Strong decrease in cadaverine uptake.
- 55 Y→L: Moderate decrease in both cadaverine excretion and cadaverine uptake.
- 57 Y→L: Strong decrease in cadaverine uptake.
- 408 E→Q: Moderate decrease in cadaverine uptake.
- 423 Y→L: Strong decrease in both cadaverine excretion and cadaverine uptake.
Query Sequence
>14398 FitnessBrowser__Keio:14398
MQTTQQNAPLKRTMKTRHLIMLSLGGVIGTGLFFNTGYIISTTGAAGTLLAYLIGALVVW
LVMQCLGELSVAMPETGAFHVYAARYLGPATGYTVAWLYWLTWTVALGSSFTAAGFCMQY
WFPQVPVWVWCVVFCAIIFGLNVISTRFFAEGEFWFSLVKVVTIIAFIILGGAAIFGFIP
MQDGSPAPGLSNITAEGWFPHGGLPILMTMVAVNFAFSGTELIGIAAGETENPRKVIPVA
IRTTIARLIIFFIGTVFVLAALIPMQQVGVEKSPFVLVFEKVGIPYAADIFNFVILTAIL
SAANSGLYASGRMLWSLSNERTLPACFARVTKNGVPLTALSVSMLGGVLALFSSVVAPDT
VFVALSAISGFAVVAVWLSICASHFVFRRRHLQQGKALSELHYRAPWYPLVPVLGFVLCL
VACVGLAFDPAQRIALWCGLPFVALCYGAYFLTQPRNAKQEPEHVAE
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory